Clinically localised prostate cancer is microsatellite stable

BJU International

Volumn 99, Issue 5, 2007, Pages 1031-1035

  Azzouzi, Abdel Rahmene ^a,b   Catto, James W F ^c   Rehman, Ishtiaq ^c   Larre, Stephane ^b   Roupret, Morgan ^b   Feeley, Kenneth M ^d   Cussenot, Oliver ^b,e   Meuth, Mark ^c   Hamdy, Freddie C ^c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^e HÔPITAL TENON   (France)

Author keywords

EMAST; Microsatellite instability; Mismatch repair system; Prostate cancer

Indexed keywords

NUCLEOTIDE;

ARTICLE; CANCER LOCALIZATION; CLINICAL FEATURE; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE LOCUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROSTATE CANCER;

DNA MISMATCH REPAIR; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 34247119624     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06723.x     Document Type: Article

References (30)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7-33
2. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-9
3. Fishel R, Lescoe MK, Rao MR et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-38
4. Bronner CE, Baker SM, Morrison PT et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258-61
5. Nicolaides NC, Papadopoulos N, Liu B et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80
6. Honchel R, Halling KC, Thibodeau SN. Genomic instability in neoplasia. Semin Cell Biol 1995; 6: 45-52
7. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997; 57: 4749-56
8. Boland CR, Thibodeau SN, Hamilton SR et al. National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-57
9. Catto JW, Azzouzi AR, Amira N et al. Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. Oncogene 2003; 54: 8699-706
10. Danaee H, Nelson HH, Karagas MR et al. Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene 2002; 32: 4894-9
11. Xu L, Chow J, Bonacum J et al. Microsatellite instability at AAAG repeat sequences in respiratory tract cancers. Int J Cancer 2001; 91: 200-4
12. Slebos RJ, Oh DS, Umbach DM, Taylor JA. Mutations in tetranucleotide repeats following DNA damage depend on repeat sequence and carcinogenic agent. Cancer Res 2002; 62: 6052-60
13. Catto JW, Xinarianos G, Burton JL, Meuth M, Hamdy FC. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer 2003; 105: 484-90
14. Terrell RB, Wille AH, Cheville JC, Nystuen AM, Cohen MB, Sheffield VC. Microsatellite instability in adenocarcinoma of the prostate. Am J Pathol 1995; 147: 799-805
15. Crundwell MC, Morton DG, Arkell DG, Phillips SM. Genetic instability in incidentally discovered and advanced prostate cancer. BJU Int 1999; 84: 123-7
16. Egawa S, Uchida T, Suyama K et al. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res 1995; 55: 2418-21
17. Uchida T, Wada C, Wang C et al. Microsatellite instability in prostate cancer. Oncogene 1995; 10: 1019-22
18. Watanabe M, Imai H, Shiraishi T, Shimazaki J, Kotake T, Yatani R. Microsatellite instability in human prostate cancer. Br J Cancer 1995; 72: 562-4
19. Cunningham JM, Shan A, Wick MJ et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 1996; 56: 4475-82
20. Dahiya R, Lee C, McCarville J, Hu W, Kaur G, Deng G. High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. Int J Cancer 1997; 72: 762-7
21. Gao X, Wu N, Grignon D et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 1994; 9: 2999-3003
22. Sun X, Chen C, Vessella RL, Dong JT. Microsatellite instability and mismatch repair target gene mutations in cell lines and xenografts of prostate cancer. Prostate 2006; 66: 660-6
23. Zhu J, Guo SZ, Beggs AH et al. Microsatellite instability analysis of primary human brain tumors. Oncogene 1996; 12: 1417-23
24. Malmer B, Gronberg H, Andersson U, Jonsson BA, Henriksson R. Microsatellite instability, PTEN and p53 germline mutations in glioma families. Acta Oncol 2001; 40: 633-7
25. Yamamoto H, Itoh F, Fukushima H et al. Infrequent widespread microsatellite instability in hepatocellular carcinomas. Int J Oncol 2000; 16: 543-7
26. Anbazhagan R, Fujii H, Gabrielson E. Microsatellite instability is uncommon in breast cancer. Clin Cancer Res 1999; 5: 839-44
27. Burger M, Denzinger S, Hammerschmied CG et al. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer. J Mol Med 2006; 84: 833-41
28. Perinchery G, Nojima D, Goharderakhshan R, Tanaka Y, Alonzo J, Dahiya R. Microsatellite instability of dinucleotide tandem repeat sequences is higher than trinucleotide, tetranucleotide and pentanucleotide repeat sequences in prostate cancer. Int J Oncol 2000; 16: 1203-9
29. Mottaz AE, Markwalder R, Fey MF et al. Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations. Prostate 1997; 31: 209-15
30. Ahrendt SA, Decker PA, Doffek K et al. Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer. Cancer Res 2000; 60: 2488-91